AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Diaglim-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Biochem Pharmaceutical Industries

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Diaglim-M2 Tablet SR

Glycemia-Duo SR tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Glycemia-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled glucose levels; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are pivotal in diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended by your healthcare provider.

Uses of Diaglim-M2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Diaglim-M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Diaglim-M2 Tablet SR with a meal.

Common Side effects of Diaglim-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Diaglim-M2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Diaglim-M2 Tablet SR with a meal.

How Diaglim-M2 Tablet SR works:

Diaglim-M2 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts through a three-pronged approach: decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Diaglim-M2 Tablet SR and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Diaglim-M2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Diaglim-M2 Tablet SR while breastfeeding is contraindicated due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are abnormally low or elevated. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Diaglim-M2 Tablet SR, potentially requiring dosage modification under medical supervision. Diaglim-M2 Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Diaglim-M2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Diaglim-M2 Tablet SR :

Should you forget a dose of Diaglim-M2 Tablet SR, take it immediately. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Diaglim-M2 Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Diaglim-M2 Tablet SR

Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Diaglim-M2 Tablet SR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this uncommon side effect of metformin poses a significant risk to individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Diaglim-M2 Tablet SR and seek immediate medical attention.
Diaglim-M2 SR tablets contain glimepiride and metformin, acting together to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a suitable diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, thereby reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. This dual-drug formulation is unsuitable for type 1 diabetes.
Diaglim-M2 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Diaglim-M2 Tablet SR use can indeed lead to Vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, according to some studies, include supplemental Vitamin B12 at least annually.
Indeed, Diaglim-M2 Tablet SR can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Consequently, consistent blood glucose monitoring is crucial. Carrying a rapidly absorbable sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Diaglim-M2 Tablet SR and alcohol is unsafe due to the risk of significantly reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination elevates the likelihood of lactic acidosis.
Diaglim-M2 Tablet SR
67
MRP 82
18% off